Charles River Laboratories (CRL) Tops Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $278.06 -1.28%
EPS Growth %: +21.8%
Financial Fact:
Net income attributable to common shareowners: 37.74M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +21.8%
Financial Fact:
Net income attributable to common shareowners: 37.74M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $0.70, $0.05 better than the analyst estimate of $0.65. Revenue for the quarter came in at $286 million versus the consensus estimate of $286.21 million.
Charles River Laboratories reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Charles River Laboratories reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Arrive AI and DXC Technology partner to bring delivery tech to factories
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
